Streetbeat News

Analyst Ratings

BFAM

UBS analyst Joshua Chan has upgraded Bright Horizons Family (NYSE:BFAM) from Sell to Neutral and raised the price target from $82 to $83.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 9:25 am

BMRN

Bernstein analyst William Pickering has upgraded Biomarin Pharmaceutical (NASDAQ:BMRN) from Underperform to Market Perform and set a price target of $82.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 9:21 am

DOCN

Piper Sandler analyst James Fish has upgraded DigitalOcean Holdings (NYSE:DOCN) from Underweight to Neutral, but lowered the price target from $30 to $22.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 9:19 am

COUR

Telsey Advisory Group analyst Sarang Vora has reiterated an 'Outperform' rating on Coursera (NYSE:COUR) and maintained a $20 price target.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 9:15 am

U

Piper Sandler analyst Brent Bracelin has downgraded Unity Software (NYSE:U) from Overweight to Neutral and lowered the price target from $48 to $30.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 9:13 am

SPT

Keybanc analyst Michael Turits has maintained an Overweight rating on Sprout Social (NASDAQ:SPT) but lowered the price target from $62 to $58.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 9:11 am

OKTA

Keybanc analyst Michael Turits has maintained an Overweight rating on Okta (NASDAQ:OKTA) but lowered the price target from $106 to $95.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 9:09 am

MDB

Keybanc analyst Michael Turits has maintained an Overweight rating on MongoDB (NASDAQ:MDB) but lowered the price target from $495 to $440.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 9:03 am

GTLB

Keybanc analyst Michael Turits has maintained an Overweight rating on GitLab (NASDAQ:GTLB), but lowered the price target from $65 to $57.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 8:58 am

FNB

Raymond James analyst Daniel Tamayo has maintained an Outperform rating on F N B (NYSE:FNB) but lowered the price target from $15 to $14.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 8:52 am